- RXRX +0.14%
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
Yahoo Finance · 2 weeks ago
Open | 7.39 |
High | 7.45 |
Low | 7.16 |
Mkt Cap | 1.99B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 7.40 |
52 Wk. Low | 4.97 |
52 Wk. High | 16.75 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 13.79M | 13.70% ▲ |
Net Income | -91.37M | - |
Diluted EPS | -0.39 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.40 | - |
Q1 2024 | -$0.42 | -$0.39 |
Q4 2023 | -$0.45 | -$0.42 |
S&P 500^GSPC | 5,576.31+3.46 (+0.06%) |
Dow 30^DJI | 39,265.29-79.50 (-0.20%) |
Nasdaq^IXIC | 18,426.69+22.95 (+0.12%) |
Soligenix, Inc.SNGX | 9.14+357.89% |
Baidu, Inc.BIDU | 95.01+8.03% |
11.14+31.68% |